228 related articles for article (PubMed ID: 23601492)
1. Induction of toxin-specific neutralizing immunity by molecularly uniform rice-based oral cholera toxin B subunit vaccine without plant-associated sugar modification.
Yuki Y; Mejima M; Kurokawa S; Hiroiwa T; Takahashi Y; Tokuhara D; Nochi T; Katakai Y; Kuroda M; Takeyama N; Kashima K; Abe M; Chen Y; Nakanishi U; Masumura T; Takeuchi Y; Kozuka-Hata H; Shibata H; Oyama M; Tanaka K; Kiyono H
Plant Biotechnol J; 2013 Sep; 11(7):799-808. PubMed ID: 23601492
[TBL] [Abstract][Full Text] [Related]
2. MucoRice-cholera toxin B-subunit, a rice-based oral cholera vaccine, down-regulates the expression of α-amylase/trypsin inhibitor-like protein family as major rice allergens.
Kurokawa S; Nakamura R; Mejima M; Kozuka-Hata H; Kuroda M; Takeyama N; Oyama M; Satoh S; Kiyono H; Masumura T; Teshima R; Yuki Y
J Proteome Res; 2013 Jul; 12(7):3372-82. PubMed ID: 23763241
[TBL] [Abstract][Full Text] [Related]
3. Oral MucoRice expressing double-mutant cholera toxin A and B subunits induces toxin-specific neutralising immunity.
Yuki Y; Tokuhara D; Nochi T; Yasuda H; Mejima M; Kurokawa S; Takahashi Y; Kataoka N; Nakanishi U; Hagiwara Y; Fujihashi K; Takaiwa F; Kiyono H
Vaccine; 2009 Oct; 27(43):5982-8. PubMed ID: 19665603
[TBL] [Abstract][Full Text] [Related]
4. A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity.
Nochi T; Yuki Y; Katakai Y; Shibata H; Tokuhara D; Mejima M; Kurokawa S; Takahashi Y; Nakanishi U; Ono F; Mimuro H; Sasakawa C; Takaiwa F; Terao K; Kiyono H
J Immunol; 2009 Nov; 183(10):6538-44. PubMed ID: 19880451
[TBL] [Abstract][Full Text] [Related]
5. Good manufacturing practices production of a purification-free oral cholera vaccine expressed in transgenic rice plants.
Kashima K; Yuki Y; Mejima M; Kurokawa S; Suzuki Y; Minakawa S; Takeyama N; Fukuyama Y; Azegami T; Tanimoto T; Kuroda M; Tamura M; Gomi Y; Kiyono H
Plant Cell Rep; 2016 Mar; 35(3):667-79. PubMed ID: 26661780
[TBL] [Abstract][Full Text] [Related]
6. Comparative whole-genome and proteomics analyses of the next seed bank and the original master seed bank of MucoRice-CTB 51A line, a rice-based oral cholera vaccine.
Sasou A; Yuki Y; Honma A; Sugiura K; Kashima K; Kozuka-Hata H; Nojima M; Oyama M; Kurokawa S; Maruyama S; Kuroda M; Tanoue S; Takamatsu N; Fujihashi K; Goto E; Kiyono H
BMC Genomics; 2021 Jan; 22(1):59. PubMed ID: 33468052
[TBL] [Abstract][Full Text] [Related]
7. Comparative whole-genome analyses of selection marker-free rice-based cholera toxin B-subunit vaccine lines and wild-type lines.
Kashima K; Mejima M; Kurokawa S; Kuroda M; Kiyono H; Yuki Y
BMC Genomics; 2015 Feb; 16(1):48. PubMed ID: 25653106
[TBL] [Abstract][Full Text] [Related]
8. Oral rice-based vaccine induces passive and active immunity against enterotoxigenic E. coli-mediated diarrhea in pigs.
Takeyama N; Yuki Y; Tokuhara D; Oroku K; Mejima M; Kurokawa S; Kuroda M; Kodama T; Nagai S; Ueda S; Kiyono H
Vaccine; 2015 Sep; 33(39):5204-11. PubMed ID: 26254309
[TBL] [Abstract][Full Text] [Related]
9. Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine.
Tokuhara D; Yuki Y; Nochi T; Kodama T; Mejima M; Kurokawa S; Takahashi Y; Nanno M; Nakanishi U; Takaiwa F; Honda T; Kiyono H
Proc Natl Acad Sci U S A; 2010 May; 107(19):8794-9. PubMed ID: 20421480
[TBL] [Abstract][Full Text] [Related]
10. RNAi-mediated suppression of endogenous storage proteins leads to a change in localization of overexpressed cholera toxin B-subunit and the allergen protein RAG2 in rice seeds.
Kurokawa S; Kuroda M; Mejima M; Nakamura R; Takahashi Y; Sagara H; Takeyama N; Satoh S; Kiyono H; Teshima R; Masumura T; Yuki Y
Plant Cell Rep; 2014 Jan; 33(1):75-87. PubMed ID: 24085308
[TBL] [Abstract][Full Text] [Related]
11. Oral MucoRice-CTB vaccine is safe and immunogenic in healthy US adults.
Yuki Y; Nojima M; Kashima K; Sugiura K; Maruyama S; Kurokawa S; Yamanoue T; Nakahashi-Ouchida R; Nakajima H; Hiraizumi T; Kohno H; Goto E; Fujihashi K; Kiyono H
Vaccine; 2022 May; 40(24):3372-3379. PubMed ID: 35484039
[TBL] [Abstract][Full Text] [Related]
12. Oral MucoRice-CTB vaccine for safety and microbiota-dependent immunogenicity in humans: a phase 1 randomised trial.
Yuki Y; Nojima M; Hosono O; Tanaka H; Kimura Y; Satoh T; Imoto S; Uematsu S; Kurokawa S; Kashima K; Mejima M; Nakahashi-Ouchida R; Uchida Y; Marui T; Yoshikawa N; Nagamura F; Fujihashi K; Kiyono H
Lancet Microbe; 2021 Sep; 2(9):e429-e440. PubMed ID: 35544149
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and immunological characterization of the plant-derived candidate human immunodeficiency virus type 1 mucosal vaccine CTB-MPR.
Matoba N; Kajiura H; Cherni I; Doran JD; Bomsel M; Fujiyama K; Mor TS
Plant Biotechnol J; 2009 Feb; 7(2):129-45. PubMed ID: 19037902
[TBL] [Abstract][Full Text] [Related]
14. N-glycosylation of cholera toxin B subunit in Nicotiana benthamiana: impacts on host stress response, production yield and vaccine potential.
Hamorsky KT; Kouokam JC; Jurkiewicz JM; Nelson B; Moore LJ; Husk AS; Kajiura H; Fujiyama K; Matoba N
Sci Rep; 2015 Jan; 5():8003. PubMed ID: 25614217
[TBL] [Abstract][Full Text] [Related]
15. [MucoRice: development of rice-based oral vaccine].
Yuki Y; Kiyono H
Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct; 31(5):369-74. PubMed ID: 18974620
[TBL] [Abstract][Full Text] [Related]
16. MucoRice-CTB line 19A, a new marker-free transgenic rice-based cholera vaccine produced in an LED-based hydroponic system.
Yuki Y; Kurokawa S; Sugiura K; Kashima K; Maruyama S; Yamanoue T; Honma A; Mejima M; Takeyama N; Kuroda M; Kozuka-Hata H; Oyama M; Masumura T; Nakahashi-Ouchida R; Fujihashi K; Hiraizumi T; Goto E; Kiyono H
Front Plant Sci; 2024; 15():1342662. PubMed ID: 38559768
[TBL] [Abstract][Full Text] [Related]
17. Seed Metabolome Analysis of a Transgenic Rice Line Expressing Cholera Toxin B-subunit.
Ogawa T; Kashima K; Yuki Y; Mejima M; Kurokawa S; Kuroda M; Okazawa A; Kiyono H; Ohta D
Sci Rep; 2017 Jul; 7(1):5196. PubMed ID: 28701756
[TBL] [Abstract][Full Text] [Related]
18. Novel transgenic rice-based vaccines.
Azegami T; Itoh H; Kiyono H; Yuki Y
Arch Immunol Ther Exp (Warsz); 2015 Apr; 63(2):87-99. PubMed ID: 25027548
[TBL] [Abstract][Full Text] [Related]
19. Rapid and scalable plant-based production of a cholera toxin B subunit variant to aid in mass vaccination against cholera outbreaks.
Hamorsky KT; Kouokam JC; Bennett LJ; Baldauf KJ; Kajiura H; Fujiyama K; Matoba N
PLoS Negl Trop Dis; 2013; 7(3):e2046. PubMed ID: 23505583
[TBL] [Abstract][Full Text] [Related]
20. RNAi suppression of rice endogenous storage proteins enhances the production of rice-based Botulinum neutrotoxin type A vaccine.
Yuki Y; Mejima M; Kurokawa S; Hiroiwa T; Kong IG; Kuroda M; Takahashi Y; Nochi T; Tokuhara D; Kohda T; Kozaki S; Kiyono H
Vaccine; 2012 Jun; 30(28):4160-6. PubMed ID: 22554467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
